Innovating Works

FUNDACION PARA LA INVESTIGACION BIOMEDIC...

Activa
TechConnect: TechConnect Assessing and Strengthening Human Tech Skill Complementarity in the Digital Landscape TechConnect thoroughly explores the ongoing debate regarding the influence of emerging technologies on human labor and skills. It places a d...
2024-09-23 - 2027-09-30 | Financiado
NeuroNanotech: Nanoplatforms for Neuroscience FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO RAMON Y CAJAL participó en un HORIZON EUROPE HORIZON-MSCA-2023-DN-01 NeuroNanotech will train eleven researchers to tackle one of the major challenges in Europe’s ageing population - neurological diseases. The...
2024-07-02 - 2028-12-31 | Financiado
PANCAID: PANcreatic CAncer Initial Detection via liquid biopsy FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO RAMON Y CAJAL participó en un HORIZON EUROPE HORIZON-MISS-2021-CANCER-02 Pancreatic cancer (PDAC) is usually detected at late stages and most patients die within one year after diagnosis. In PANCAID we will theref...
2022-12-02 - 2027-12-31 | Financiado
METEOR study: MicrobiomE-associaTEd boosters Of immune Responses (METEOR study): experimental charac-terization an... FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO RAMON Y CAJAL tramitó un HORIZON EUROPE HORIZON-MSCA-2021-PF-01 I became fascinated by pathogen-host interactions at the end of my PhD, working with Hepatitis C virus, and later in my first postdoctoral p...
2022-06-22 - 2025-12-31 | Financiado
RESILIENCE: Remote Ischemic Conditioning in Lymphoma Patients Receiving Anthracyclines. FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO RAMON Y CAJAL participó en un H2020 H2020-SC1-BHC-2018-2020 The increasing life expectancy of the population and the development of effective therapies result in a growing population of aged cancer su...
2021-01-29 - 2026-05-31 | Financiado
REPLAY: Analysing the role of history chance and selection on the evolution of plasmid mediated antibiotic... FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO RAMON Y CAJAL tramitó un H2020 H2020-MSCA-IF-2019 Antimicrobial resistance (AMR) in bacteria is one of the main challenges faced by modern medicine and understanding its evolution is urgentl...
2020-03-24 - 2022-10-31 | Financiado
VISION: Strategies to strengthen scientific excellence and innoVation capacIty for early diagnoSIs of gastrO... FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO RAMON Y CAJAL participó en un H2020 H2020-WIDESPREAD-2018-2020 Slovakia belongs to countries with the highest incidence of colorectal and pancreatic cancer in Europe. Therefore, the main goal of the VISI...
2019-07-09 - 2023-06-30 | Financiado
CARDIATEAM: CARdiomyopathy in type 2 DIAbetes mellitus FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO RAMON Y CAJAL participó en un H2020 H2020-JTI-IMI2-2017-13-two-stage A rapidly evolving epidemic in Type 2 Diabetes (T2DM) is afflicting all ages, sexes and socioeconomic classes which includes serious comorbi...
2019-04-11 - 2026-02-28 | Financiado
NanoTBTech: Nanoparticles based 2D thermal bioimaging technologies FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO RAMON Y CAJAL participó en un H2020 H2020-FETOPEN-2016-2017 Temperature measurements are crucial in countless technological developments, accounting for 80% of the sensor market throughout the world....
2018-05-04 - 2022-02-28 | Financiado
PurinesDX: Interdisciplinary training network on the purinergic P2X7 receptor to control neuroinflammation and... FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO RAMON Y CAJAL participó en un H2020 H2020-MSCA-ITN-2017 Brain disorders affect ~179 million people and their families in Europe alone, with an annual cost to the taxpayer estimated at €800 billion...
2017-08-17 - 2021-08-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.